Floatz logo

[14c]-a4250

Progressive Familial Intrahepatic Cholestasis

AlbireoPhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Progressive Familial Intrahepatic Cholestasis cohort.

Asset / SponsorPhaseRating
lum001
Mirum Pharmaceuticals, Inc.
Phase 2B
ODEVIXIBAT
Albireo
Phase 1CCC
Questran
Albireo
Phase 1CC
Cholestyramine
Albireo
Phase 1CC
lum001
Mirum Pharmaceuticals, Inc.
Phase 2NR

Same molecule, other indications

[14c]-a4250 is also rated in:

cholestasisDormant
CC
Indicative ·
47 / 100
View asset →
Alagille syndromeDormant
CC
Indicative ·
47 / 100
View asset →
primary biliary cholangitisDormant
CC
Indicative ·
47 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →